Brussels, Brussels Hoofdstedelijk Gewest, Belgium We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline DNA Script, Sol Voltaics, Infarm Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The common things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this Horizon 2020 performs on 25 percentage points less the average number of lead investments. The important activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 41 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Horizon 2020 is 1-5 millions dollars.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Horizon 2020, startups are often financed by Venture Kick, Tekes, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are EASME - EU Executive Agency for SMEs, Tekes, Maki.vc. In the next rounds fund is usually obtained by European Bank for Reconstruction and Development, EIT Health, UCLB.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MUVON Therapeutics | 31 May 2021 | Zürich, Zurich, Switzerland | |||
Qblox | $5M | 11 Jan 2021 | South Holland | ||
Satelligence | $2M | 25 Nov 2020 | Utrecht, Utrecht, The Netherlands | ||
Ovon Home | $73K | 01 Oct 2020 | Manchester, England, United Kingdom | ||
BotsAndUs | $2M | 06 Jul 2020 | London, England, United Kingdom | ||
CyanoGuard AG | $3M | 14 Apr 2020 | Zurich, Switzerland | ||
Coffee Cloud | $890K | 01 Jan 2020 | London, England, United Kingdom | ||
ultimate.ai | $3M | 04 Nov 2019 | Berlin, Berlin, Germany | ||
Sorek Medical Systems | $2M | 01 Oct 2019 | Israel, North District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MUVON Therapeutics | 31 May 2021 | Zürich, Zurich, Switzerland | |||
Qblox | $5M | 11 Jan 2021 | South Holland | ||
Satelligence | $2M | 25 Nov 2020 | Utrecht, Utrecht, The Netherlands | ||
Ovon Home | $73K | 01 Oct 2020 | Manchester, England, United Kingdom | ||
BotsAndUs | $2M | 06 Jul 2020 | London, England, United Kingdom | ||
CyanoGuard AG | $3M | 14 Apr 2020 | Zurich, Switzerland | ||
Coffee Cloud | $890K | 01 Jan 2020 | London, England, United Kingdom | ||
ultimate.ai | $3M | 04 Nov 2019 | Berlin, Berlin, Germany | ||
Sorek Medical Systems | $2M | 01 Oct 2019 | Israel, North District, Israel |
